Lunai Bioworks (LNAI) Enterprise Value (2011 - 2026)
Lunai Bioworks (LNAI) recorded quarterly Enterprise Value of -$3.2 million in Q1 2026, down 541.78% quarter-over-quarter from -$491645.0 in Q4 2025, and down 93.19% on a YoY basis from -$46.3 million in Q1 2025.
Lunai Bioworks (LNAI) Enterprise Value (2011 - 2026) Analysis & Trends
Lunai Bioworks' Enterprise Value history runs 16 years deep, the most recent figure standing at -$3.2 million for Q1 2026.
- In Q1 2026, Enterprise Value fell 93.19% year-over-year to -$3.2 million; the TTM figure through Mar 2026 stood at -$3.2 million (down 93.19% YoY), while the FY2025 annual figure was -$480551.0, down 117.97% from the prior year.
- Enterprise Value was -$3.2 million for Q1 2026 at Lunai Bioworks, down from -$491645.0 in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$220467.0 in Q2 2024 to a low of -$11.2 million in Q1 2022.
- Historically, Enterprise Value has averaged -$2.7 million across 5 years, with a median of -$624808.0 in 2025.
- The sharpest annual moves came in 2023 and 2025: Enterprise Value surged 94.08% in 2023, then tumbled 422.32% in 2025.
- A 5-year view of Enterprise Value shows it stood at -$4.1 million in 2022, then soared by 94.08% to -$243980.0 in 2023, then slipped by 27.78% to -$311764.0 in 2024, then sank by 57.7% to -$491645.0 in 2025, then sank by 541.78% to -$3.2 million in 2026.
- The last three Enterprise Value figures came in at -$3.2 million (Q1 2026), -$491645.0 (Q4 2025), and -$624808.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -32.30 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -4.14 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -286.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -18.44 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.77 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -7.20 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -7.25 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -584.73 Mn |
| 10 | Lunai Bioworks | 95.85 Mn | 92.70 Mn | 20,942.00 | -3.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.16 Mn |
| Dec 31, 2025 | -491,645.00 |
| Sep 30, 2025 | -624,808.00 |
| Jun 30, 2025 | -480,551.00 |
| Mar 31, 2025 | -1.63 Mn |
| Dec 31, 2024 | -311,764.00 |
| Sep 30, 2024 | -220,571.00 |
| Jun 30, 2024 | -220,467.00 |
| Mar 31, 2024 | -312,697.00 |
| Dec 31, 2023 | -243,980.00 |
| Sep 30, 2023 | -523,474.00 |
| Jun 30, 2023 | -1.87 Mn |
| Mar 31, 2023 | -2.95 Mn |
| Dec 31, 2022 | -4.12 Mn |
| Sep 30, 2022 | -7.97 Mn |
| Jun 30, 2022 | -9.17 Mn |
| Mar 31, 2022 | -11.15 Mn |
| Dec 31, 2021 | -13.71 Mn |
| Sep 30, 2021 | -15.38 Mn |
| Jun 30, 2021 | -20.66 Mn |